Preterm Rupture of Membranes clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 18-55
This study evaluates the use of metagenomic next generation sequencing in identifying microbial DNA in plasma samples of patients with preterm premature rupture of membranes.
Our lead scientists for Preterm Rupture of Membranes research studies include Nasim C Sobhani, MD.